BioLytical
Federal opportunity from Department of Health. Place of performance: FL. Response deadline: Jul 10, 2026.
- Source
- Open on official portal →
- Solicitation
- c22b88fc01ca0e27535a03f09bd77e8e
- Performance
- Tallahassee, FL
- Response
- Jul 10, 2026, 02:00 PM UTC
Point of Contact
Agency & Office
Applicable wage determinations
Best public WD match for the notice location and scope.
View more WD detail3 more WD matches and 18 more rate previews.↓
Description
<p>The FDOH, Bureau of Communicable Disease, has a need to purchase INSTI HIV-1/HIV-2 Antibody Tests that can detect HIV antibodies up to 9 days earlier than the Western Blot, in order to provide earlier detection and response time. Early detection enables immediate medical care and transmission prevention, protecting public health and stopping the spread of disease. </p><p>In accordance with Chapter 60A-1.045, F.A.C. The Florida Department of Health, Bureau of Communicable Disease, HIV/AIDS Section requests authorization to purchase as a single source, INSTI HIV-1/HIV-2 Antibody Tests from BioLytical Laboratories Inc</p>
Pricing and bid posture
Contractor-side estimate from visible notice metadata, NAICS/PSC, contract type, schedule hints, and BidPulsar workpaper assumptions. Not an IGCE, incumbent price, award value, or government budget.
This advisory bid range is visible page text for contractors and search engines: it summarizes the modeled floor, target, and premium bid posture for this solicitation.
Market snapshot
Baseline awarded-market signal across all contracting (sample of 400 recent awards; refreshed periodically).
Files
Files size/type shown when available.
BidPulsar Analysis
A practical, capture-style breakdown of fit, requirements, risks, and next steps.
Service match
Optional support routes matched to this notice after the core solicitation details.
Related hubs & trends
Navigate the lattice: hubs for browsing, trends for pricing signals.